Rhenman & Partners Asset Management AB
Top Portfolio Positions
86 positions ·
$810,489,947 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| BSX |
Boston Scientific Corp
Healthcare
|
625,000 | $39,218,750 | 4.84% |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
48,100 | $37,163,984 | 4.59% |
| LLY |
ELI LILLY & Co
Healthcare
|
33,715 | $31,010,045 | 3.83% |
| INSM |
INSMED Inc
Healthcare
|
159,760 | $26,123,955 | 3.22% |
| CVS |
CVS HEALTH Corp
Healthcare
|
336,500 | $24,167,430 | 2.98% |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
167,750 | $23,379,317 | 2.88% |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
41,340 | $20,319,850 | 2.51% |
| BIIB |
Biogen Inc.
Healthcare
|
109,100 | $20,001,303 | 2.47% |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
43,485 | $19,417,791 | 2.40% |
| ALHC |
Alignment Healthcare, Inc.
Healthcare
|
1,053,450 | $18,561,789 | 2.29% |
Portfolio Trend
Holdings in PRCT
Shares Held
Position Value (USD)
12 of 12 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,879,750 | 475,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $19,222,060 | 611,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,919,100 | 390,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,944,000 | 190,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $26,100,480 | 448,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $33,846,179 | 420,345 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $35,653,400 | 445,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $26,879,600 | 440,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $24,070,653 | 487,063 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $12,992,100 | 310,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $16,175,330 | 493,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,862,650 | 279,000 | Shares | Sole | 2023-08-11 | |
| No quarters match your search. | ||||||